GILEAD 701 (Truvada 200 mg / 300 mg)

Generic Name: emtricitabine/tenofovir

Pill imprint GILEAD 701 has been identified as Truvada 200 mg / 300 mg.

Truvada is used in the treatment of pre-exposure prophylaxis; hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Truvada 200 mg / 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Truvada

Generic Name:

emtricitabine/tenofovir

Imprint:

GILEAD 701

Strength:

200 mg / 300 mg

Color:

Blue

Size:

19.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Antiviral combinations

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Gilead Sciences

National Drug Code (NDC):

61958-0701

Inactive Ingredients:

croscarmellose sodium
lactose monohydrate
magnesium stearate
microcrystalline cellulose
corn starch
water
FD&C Blue No. 2
aluminum oxide
hypromelloses
titanium dioxide
triacetin

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
54569-5588	A-S Medication Solutions, LLC (repackager)
54868-5141	Physicians Total Care Inc (repackager)
55045-3481	Dispensing Solutions Inc. (repackager)
35356-0070	Lake Erie Medical and Surgical Supply (repackager)
52959-0969	H.J. Harkins Company, Inc (repackager)
68258-1983	Dispensing Solutions Inc. (repackager)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.